Anterix Board Approves $250M Share Repurchase Authorization
ATEX has more than doubled off its 52-week low of $17.58 on elevated volume (2.0× avg).
Summary
A new $250 million share repurchase program has been authorized, effective September 22, 2026, replacing the expiring prior program.
Key Events · Financing and Capital Events · ATEX
-
$250M Buyback Authorized
The board has authorized up to $250 million in share repurchases, effective September 22, 2026, through September 22, 2029.
-
Replaces Expiring Program
The new program takes effect the day after the prior repurchase program expires on September 21, 2026.
-
Flexible Execution
Repurchases may be made via open market or privately negotiated transactions, including Rule 10b5-1 trading plans.
-
No Minimum Commitment
The program does not obligate Anterix to repurchase any particular amount and may be suspended, discontinued, or modified at any time.
Analysis · ATEX · Technology
A new $250 million share repurchase program has been authorized by the board, effective September 22, 2026, replacing the prior program that expires September 21, 2026. This authorization represents roughly 16.6% of the company's current market capitalization, signaling a meaningful commitment to returning capital. Repurchases may be executed through open market or private transactions, including Rule 10b5-1 plans, and the program runs through September 22, 2029. The company is not obligated to repurchase any specific amount and may suspend or modify the program at any time.
How filings like this one have moved
In the 30 days to Oct 18, 2026, 29.4% of the 1431 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ATEX was trading at $78.17 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $17.58 to $113.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.